BBIO- Bridgebio Pharma, Inc.

Name: Bridgebio Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 47 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
?	Viking Global Investors LP	18.56M	$1.23B	-
10%	Bridgebio Pharma LLC	14.59M	$966.87M	-
CEO	Kumar Neil	4.40M	$291.49M	-
Dir	Homcy Charles J	916.7K	$60.75M	-
Dir	McCormick Frank	766.6K	$50.80M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 15, 2026	Cook Jennifer E.60	Director	Sale+OE	90,240	$66.62	$6,012,157.05	-86.0%	-	-
Apr 10, 2026	Kumar Neil	Chief Executive Officer	Sell	80,000	$74.61	$5,968,780.10	-0.4%	-	-
Mar 10, 2026	Valantine Hannah53	Director	Sale+OE	8,671	$72.00	$624,312.00	-53.7%	-9.1%	-
Jan 9, 2026	Kumar Neil	Chief Executive Officer	Sell	80,000	$75.54	$6,043,168.23	-0.2%	-2.2%	-
Dec 15, 2025	Kumar Neil	Chief Executive Officer	Sale+OE	30,011	$74.64	$2,239,902.15	-6.1%	-4.7%	-
Dec 8, 2025	Apuli Maricel	Chief Accounting Officer	Sell	2,000	$74.26	$148,520.00	-1.5%	-11.6%	-
Dec 5, 2025	Kumar Neil	Chief Executive Officer	Sell	80,000	$73.86	$5,908,475.89	-0.3%	-10.0%	-
Nov 20, 2025	Kumar Neil	Chief Executive Officer	Sell	26,156	$65.84	$1,722,223.69	-3.5%	+14.4%	-
Nov 18, 2025	Lo Andrew	Director	Sell	95,599	$66.11	$6,319,662.43	-36.8%	+15.6%	-
Nov 17, 2025	Scott Randal W.45	Director	Sale+OE	10,000	$66.65	$666,465.10	-25.4%	+13.4%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC